Regarding TT+ T cells, total numbers (Figure 5A) and proliferation (Figure 5B) of TT+ CD4 cells were significantly lower in RTX patients compared with HC, but similar when compared with RA group, suggesting rather a disease than a therapy specific effect. Here, CD4 is linked to rheumatoid arthritis.